104 related articles for article (PubMed ID: 2511580)
1. [Moclobemide in the long-term treatment of depressed patients].
Carl G; Laux G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():48-50. PubMed ID: 2511580
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of depression using MAO-A inhibitors: an open study of a direct switch from moclobemide to tri-/tetracyclic antidepressants].
Becker T; Struck M; Laux G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():44-7. PubMed ID: 2685856
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy using moclobemide with tricyclic and tetracyclic antidepressants to treat therapy-resistant depression.
König F; Wolfersdorf M
Pharmacopsychiatry; 1997 May; 30(3):93-6. PubMed ID: 9211570
[TBL] [Abstract][Full Text] [Related]
4. What happens to patients after the end of a clinical trial? Systematic follow-up observational study of an open moclobemide trial in major depression.
Linden M; Baier D; Gothe H; Kohnen R
Pharmacopsychiatry; 1997 Jan; 30(1 Suppl):35-43. PubMed ID: 9035226
[TBL] [Abstract][Full Text] [Related]
5. Trimipramine and maprotiline plasma levels during combined treatment with moclobemide in therapy-resistant depression.
König F; Wolfersdorf M; Löble M; Wössner S; Hauger B
Pharmacopsychiatry; 1997 Jul; 30(4):125-7. PubMed ID: 9271778
[TBL] [Abstract][Full Text] [Related]
6. [Psychometric findings in treatment using the selective MAO-A inhibitors moclobemide and maprotiline].
Classen W
Psychiatr Prax; 1989 Aug; 16 Suppl 1():41-3. PubMed ID: 2587675
[TBL] [Abstract][Full Text] [Related]
7. [Treatment with selective and reversible monoamine oxidase inhibitors in depressed patients: is there a biological effect proportional to the dose?].
Radat F; Berlin I; Varoquaux O; Ferreri M; Puech A
Ann Med Psychol (Paris); 1996 Jun; 154(3):204-6. PubMed ID: 8766502
[No Abstract] [Full Text] [Related]
8. [Customary antidepressive treatment in Hungary: moclobemid therapy in everyday practice].
Bartkó G
Orv Hetil; 1997 Sep; 138(37):2341-5. PubMed ID: 9340582
[TBL] [Abstract][Full Text] [Related]
9. Preliminary experience with moclobemide for the treatment of depressive disorders in Malaysia.
Indran SK
Singapore Med J; 1995 Apr; 36(2):189-90. PubMed ID: 7676265
[TBL] [Abstract][Full Text] [Related]
10. Treatment of atypical depression with moclobemide: a sequential double controlled study.
Schweitzer I; Tiller J; Maguire K; Davies B
Int J Clin Pharmacol Res; 1989; 9(2):111-7. PubMed ID: 2654034
[TBL] [Abstract][Full Text] [Related]
11. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
[TBL] [Abstract][Full Text] [Related]
12. [Preventive treatment of migraine and chronic tension headache with moclobemide].
Meienberg O; Amsler F
Praxis (Bern 1994); 1997 Jul; 86(27-28):1107-12. PubMed ID: 9324719
[TBL] [Abstract][Full Text] [Related]
13. A controlled double-blind trial of moclobemide and imipramine in the treatment of depression.
Kok LP; Tsoi WF
Singapore Med J; 1995 Feb; 36(1):38-40. PubMed ID: 7570133
[TBL] [Abstract][Full Text] [Related]
14. Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression.
Ramasubbu R
J Psychiatry Neurosci; 1999 Jan; 24(1):45-50. PubMed ID: 9987207
[TBL] [Abstract][Full Text] [Related]
15. Social phobia: long-term treatment outcome and prediction of response--a moclobemide study.
Versiani M; Amrein R; Montgomery SA
Int Clin Psychopharmacol; 1997 Sep; 12(5):239-54. PubMed ID: 9466158
[TBL] [Abstract][Full Text] [Related]
16. Efficacy in long-term treatment of depression.
Montgomery SA
J Clin Psychiatry; 1996; 57 Suppl 2():24-30. PubMed ID: 8626360
[TBL] [Abstract][Full Text] [Related]
17. Eighteen months of drug treatment for depression: predicting relapse and recovery.
Mulder RT; Frampton CM; Luty SE; Joyce PR
J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
[TBL] [Abstract][Full Text] [Related]
18. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
19. [Moclobemide in the treatment of depression--an overview].
Laux G
Psychiatr Prax; 1989 Aug; 16 Suppl 1():37-40. PubMed ID: 2685855
[TBL] [Abstract][Full Text] [Related]
20. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
Hollon SD; DeRubeis RJ; Shelton RC; Amsterdam JD; Salomon RM; O'Reardon JP; Lovett ML; Young PR; Haman KL; Freeman BB; Gallop R
Arch Gen Psychiatry; 2005 Apr; 62(4):417-22. PubMed ID: 15809409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
